Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice

被引:0
|
作者
Martinez, X
Li, XM
Kovarik, J
Klein, M
Lambert, PH
Siegrist, CA
机构
[1] Univ Geneva, Sch Med, Dept Pathol, WHO Collaborating Ctr Neonatal Vaccinol, CH-1211 Geneva, Switzerland
[2] Univ Geneva, Sch Med, Dept Pediat, CH-1211 Geneva, Switzerland
[3] Pasteur Merieux Connaught Canada, Res Ctr, N York, ON, Canada
关键词
respiratory syncytial virus; DNA vaccine; neonate; infant; maternal antibody;
D O I
10.1002/(SICI)1521-4141(199910)29:10<3390::AID-IMMU3390>3.0.CO;2-A
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early life responses to respiratory syncytial virus (RSV)-F DNA and RSV-F protein immunization were studied in murine models of neonatal immunization. RSV-F DNA induced similar antibody (Ab) responses, antigen-specific IFN-gamma production and cytotoxic T lymphocyte (CTL) responses in 1-week-old and adult BALB/c mice. In contrast, RSV-F protein induced much higher IL-5 responses in early life. Both vaccines elicited Ab and CTL responses in spite of maternal Ab, but with distinctive kinetics. Sequential RSV-F DNA priming/protein boosting primed 1-week-old mice for RSV-F-specific CTL responses, reduced IL-5 production and enhanced Ab responses. In contrast, IL-5 exceeded IFN-gamma responses when young mice were primed with protein and boosted with DNA. Last, when protein and DNA immunization were combined, a single vaccine dose induced early Ab responses, preferential IL-5 responses but strong CTL responses. Sequential or combined DNA/protein immunization thus represent interesting strategies for early life immunization.
引用
收藏
页码:3390 / 3400
页数:11
相关论文
共 50 条
  • [41] Advances in and the potential of vaccines for respiratory syncytial virus
    Jorquera, Patricia A.
    Oakley, Katie E.
    Tripp, Ralph A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (04) : 411 - 427
  • [42] Respiratory syncytial virus vaccines: recent developments
    Piedra, PA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (08) : 805 - 808
  • [43] The road to approved vaccines for respiratory syncytial virus
    Ruckwardt, Tracy J.
    NPJ VACCINES, 2023, 8 (01)
  • [44] Clinical experience with respiratory syncytial virus vaccines
    Piedra, PA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (02) : S94 - S99
  • [45] Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
    Topalidou, Xanthippi
    Kalergis, Alexis M.
    Papazisis, Georgios
    PATHOGENS, 2023, 12 (10):
  • [46] Early Life Respiratory Syncytial Virus Infection and Asthmatic Responses
    Ptaschinski, Catherine
    Lukacs, Nicholas W.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2019, 39 (03) : 309 - +
  • [47] Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy
    Simoes, Eric A. F.
    Center, Kimberly J.
    Tita, Alan T. N.
    Swanson, Kena A.
    Radley, David
    Houghton, John
    McGrory, Stephanie B.
    Gomme, Emily
    Anderson, Marquita
    Roberts, John P.
    Scott, Daniel A.
    Jansen, Kathrin U.
    Gruber, William C.
    Dormitzer, Philip R.
    Gurtman, Alejandra C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (17): : 1615 - 1626
  • [48] Early-Life Wheezing and Respiratory Syncytial Virus Prevention
    Lemanske, Robert F., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (19): : 1839 - 1841
  • [49] Protection against influenza B virus infection by immunization with DNA vaccines
    Chen, Z
    Kadowaki, S
    Hagiwara, Y
    Yoshikawa, T
    Sata, T
    Kurata, T
    Tamura, S
    VACCINE, 2001, 19 (11-12) : 1446 - 1455
  • [50] DNA vaccines for prophylactic or therapeutic immunization against hepatitis B virus
    Davis, HL
    MOUNT SINAI JOURNAL OF MEDICINE, 1999, 66 (02): : 84 - 90